Skip to content

A phase II trial of Decompression Surgery and Postoperative Stereotactic Body Radiotherapy for Metastatic Epidural Spinal Cord Compression

A phase II trial of Decompression Surgery and Postoperative Stereotactic Body Radiotherapy for Metastatic Epidural Spinal Cord Compression - Decompression Surgery and Postoperative SBRT for MESCC

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030056
Enrollment
33
Registered
2017-11-21
Start date
2017-11-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Epidural Spinal Cord Compression

Interventions

Surgical decompression and postoperative stereotactic body radiotherapy of 24 Gy in 2 fractions.

Sponsors

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. pathological or clinical diagnosis of primary cancer (including sarcoma) 2. spine metastases confirmed by images 3. Symptoms by the tumor 4. Bilsky grade is more than Ib 5. Age; 20- 6. Other lesions are controlled, or the lesion was irradiated previously 7. prognosis is expected more than 6 months 8. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Radiosensitive histology 2. the lesion was irradiated within 3 months 3. the lesion was treated with SBRT 4. untlerable to surgery 5. complete paralysis more than 48 hours 6. impossible to conduct decompression surgery

Design outcomes

Primary

MeasureTime frame
Local control at 1 year

Secondary

MeasureTime frame
Ambulatory function, OS, local progression free survival, pattern of failure, pain response, Adverse events, QOL

Countries

Japan

Contacts

Public ContactKei Ito

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Division of Radiation Oncology, Department of Radiology

keiito@cick.jp03-3823-2101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026